These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

316 related items for PubMed ID: 15168385

  • 1. Adiponectin in peritoneal dialysis patients: a comparison with hemodialysis patients and subjects with normal renal function.
    Huang JW, Yen CJ, Chiang HW, Hung KY, Tsai TJ, Wu KD.
    Am J Kidney Dis; 2004 Jun; 43(6):1047-55. PubMed ID: 15168385
    [Abstract] [Full Text] [Related]

  • 2. Serum concentrations of leptin, adiponectin and resistin, and their relationship with cardiovascular disease in patients with end-stage renal disease.
    Díez JJ, Iglesias P, Fernández-Reyes MJ, Aguilera A, Bajo MA, Alvarez-Fidalgo P, Codoceo R, Selgas R.
    Clin Endocrinol (Oxf); 2005 Feb; 62(2):242-9. PubMed ID: 15670203
    [Abstract] [Full Text] [Related]

  • 3. Comparing Dialysis Modality and Cardiovascular Mortality in Patients on Hemodialysis and Peritoneal Dialysis.
    Refaat H, Sany D, Mohab A, Ezzat H.
    Adv Perit Dial; 2016 Feb; 32():22-31. PubMed ID: 28988586
    [Abstract] [Full Text] [Related]

  • 4. Association of adiponectin with cardiovascular events in diabetic and non-diabetic hemodialysis patients.
    Elokely A, Shoukry A, Ghonemy TA, Atia M, Amr G.
    Saudi J Kidney Dis Transpl; 2012 Jul; 23(4):736-42. PubMed ID: 22805386
    [Abstract] [Full Text] [Related]

  • 5. Inverse Relationship between Plasma Tumor Necrosis Factor-Like Weak Inducer of Apoptosis and Carotid Intima-Media Thickness among Patients Undergoing Hemodialysis and Peritoneal Dialysis.
    Shi X, Qiu B, Shen H, Feng S, Fu J.
    Cardiorenal Med; 2020 Jul; 10(3):137-144. PubMed ID: 32126565
    [Abstract] [Full Text] [Related]

  • 6. Association of adiponectin and leptin with serum lipids and erythrocyte omega-3 and omega-6 fatty acids in dialysis patients.
    An WS, Son YK, Kim SE, Kim KH, Bae HR, Lee S, Park Y, Kim HJ, Vaziri ND.
    Clin Nephrol; 2011 Mar; 75(3):195-203. PubMed ID: 21329629
    [Abstract] [Full Text] [Related]

  • 7. Serum leptin, resistin, and lipid levels in patients with end stage renal failure with regard to dialysis modality.
    Taskapan MC, Taskapan H, Sahin I, Keskin L, Atmaca H, Ozyalin F.
    Ren Fail; 2007 Mar; 29(2):147-54. PubMed ID: 17365928
    [Abstract] [Full Text] [Related]

  • 8. Electronegative LDL and lipid abnormalities in patients undergoing hemodialysis and peritoneal dialysis.
    Lobo J, Santos F, Grosso D, Lima R, Barreira AL, Leite M, Mafra D, Abdalla DS.
    Nephron Clin Pract; 2008 Mar; 108(4):c298-304. PubMed ID: 18434752
    [Abstract] [Full Text] [Related]

  • 9. Growth hormone, IGF-I and its binding proteins (IGFBP-1 and -3) in adult uraemic patients undergoing peritoneal dialysis and haemodialysis.
    Iglesias P, Díez JJ, Fernández-Reyes MJ, Méndez J, Bajo MA, Aguilera A, Selgas R.
    Clin Endocrinol (Oxf); 2004 Jun; 60(6):741-9. PubMed ID: 15163339
    [Abstract] [Full Text] [Related]

  • 10. Association between body mass index and body fat in chronic kidney disease stages 3 to 5, hemodialysis, and peritoneal dialysis patients.
    Leinig C, Pecoits-Filho R, Nascimento MM, Gonçalves S, Riella MC, Martins C.
    J Ren Nutr; 2008 Sep; 18(5):424-9. PubMed ID: 18721737
    [Abstract] [Full Text] [Related]

  • 11. Adiponectin in children on peritoneal dialysis: relationship to insulin resistance and nutritional status.
    Kamariski M, Biscardi M, Cestino L, Miatello R, Guntsche E, Valles PG.
    Nephron Clin Pract; 2009 Sep; 113(1):c24-32. PubMed ID: 19590232
    [Abstract] [Full Text] [Related]

  • 12. Dialysis outcomes in Colombia (DOC) study: a comparison of patient survival on peritoneal dialysis vs hemodialysis in Colombia.
    Sanabria M, Muñoz J, Trillos C, Hernández G, Latorre C, Díaz CS, Murad S, Rodríguez K, Rivera A, Amador A, Ardila F, Caicedo A, Camargo D, Díaz A, González J, Leguizamón H, Lopera P, Marín L, Nieto I, Vargas E.
    Kidney Int Suppl; 2008 Apr; (108):S165-72. PubMed ID: 18379541
    [Abstract] [Full Text] [Related]

  • 13. The effect of HMG-CoA reductase inhibitor on insulin resistance in patients undergoing peritoneal dialysis.
    Doh FM, Chang TI, Koo HM, Lee MJ, Shin DH, Kim CH, Ko KI, Oh HJ, Yoo TH, Kang SW, Han DS, Han SH.
    Cardiovasc Drugs Ther; 2012 Dec; 26(6):501-9. PubMed ID: 22956052
    [Abstract] [Full Text] [Related]

  • 14. Resistin serum levels are increased but not correlated with insulin resistance in chronic hemodialysis patients.
    Filippidis G, Liakopoulos V, Mertens PR, Kiropoulos T, Stakias N, Verikouki C, Patsidis E, Koukoulis G, Stefanidis I.
    Blood Purif; 2005 Dec; 23(6):421-8. PubMed ID: 16141714
    [Abstract] [Full Text] [Related]

  • 15. Adiponectin levels and atherosclerotic risk factors in pediatric chronic peritoneal dialysis patients.
    Bakkaloglu SA, Buyan N, Funahashi T, Pasaoglu H, Elhan AH, Hasanoglu E, Soylemezoglu O.
    Perit Dial Int; 2005 Dec; 25(4):357-61. PubMed ID: 16022092
    [Abstract] [Full Text] [Related]

  • 16. Adiponectin in chronic kidney disease is related more to metabolic disturbances than to decline in renal function.
    Guebre-Egziabher F, Bernhard J, Funahashi T, Hadj-Aissa A, Fouque D.
    Nephrol Dial Transplant; 2005 Jan; 20(1):129-34. PubMed ID: 15585515
    [Abstract] [Full Text] [Related]

  • 17. Cardiovascular risk factors in hemodialysis and peritoneal dialysis patients.
    Helal I, Smaoui W, Hamida FB, Ouniss M, Aderrahim E, Hedri H, Elyounsi F, Maiz HB, Abdallah TB, Kheder A.
    Saudi J Kidney Dis Transpl; 2010 Jan; 21(1):59-62. PubMed ID: 20061694
    [Abstract] [Full Text] [Related]

  • 18. Circulating soluble vascular cell adhesion molecule 1: relationships with residual renal function, cardiac hypertrophy, and outcome of peritoneal dialysis patients.
    Wang AY, Lam CW, Wang M, Woo J, Chan IH, Lui SF, Sanderson JE, Li PK.
    Am J Kidney Dis; 2005 Apr; 45(4):715-29. PubMed ID: 15806475
    [Abstract] [Full Text] [Related]

  • 19. Do insulin resistance conditions further impair the lipid and inflammatory profile in end-stage renal disease patients on hemodialysis?
    Cacciagiú L, González AI, Elbert A, De'Marziani G, Machida T, Murakami M, López GI, Wikinski R, Nakajima K, Schreier L.
    Metab Syndr Relat Disord; 2014 May; 12(4):220-6. PubMed ID: 24601848
    [Abstract] [Full Text] [Related]

  • 20. The relationship between inflammatory markers, leptin and adiponectin in chronic hemodialysis patients.
    Lee CT, Lee CH, Su Y, Chuang YC, Tsai TL, Cheni JB.
    Int J Artif Organs; 2004 Oct; 27(10):835-41. PubMed ID: 15560677
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.